Quick Answer
ADAPTIN BIO, INC. reported Stockholders Equity of -$274.1 thousand for fiscal year 2024.
ADAPTIN BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$274.1K | -142.7% |
| 2023 | -$112.9K | -313.5% |
| 2022 | -$27.3K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$881.1K | +72.8% | -285.7% |
| June 30, 2025 | $474.4K | +122.2% | -72.8% |
| March 31, 2025 | $1.75M | +232.5% | +142.6% |
| December 31, 2024 | -$4.10M | -319.4% | -26.4% |
| September 30, 2024 | -$3.24M | -4018.9% | -51.9% |
| June 30, 2024 | -$2.14M | -5865.1% | -62.2% |
| March 31, 2024 | -$1.32M | -4073.8% | -34.7% |
| December 31, 2023 | -$977.6K | -3480.3% | -1141.5% |
- ADAPTIN BIO, INC. showed a decrease of -142.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2024 period, ADAPTIN BIO, INC.’s stockholders equity has declined by 903.7% (from -$27.3 thousand to -$274.1 thousand).
- The most recent figure is from ADAPTIN BIO, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: